Ocular drug delivery is a challenging field due to the unique anatomical and physiological
barriers of the eye. Biodegradable polymers have emerged as promising tools for efficient …

Glaucoma is a leading cause of irreversible visual impairment and blindness, affecting over
76.0 million people worldwide in 2020, with a predicted increase to 111.8 million by 2040 …

Despite the existence of numerous eye drops in the market, most of them are not sufficiently
effective because of quick clearance and the barriers within the eye. To increase the delivery …

Chronic ocular diseases can seriously impact the eyes and could potentially result in
blindness or serious vision loss. According to the most recent data from the WHO, there are …

Topical anti-glaucomatous medications are still the most important measure to lower
intraocular pressure. Large number of studies have confirmed that long-term use of anti …

Glaucoma is known to be one of the principal causes of vision loss due to elevated
intraocular pressure. Currently, latanoprost eye drops is used as first-line treatment for …

Surgery has long been an important treatment for limiting optic nerve damage and
minimising visual loss in patients with glaucoma. Numerous improvements, modifications …

Topical glaucoma medications have favorable safety and efficacy, but their use is limited by
factors such as side effects, nonadherence, costs, ocular surface disease, intraocular …

Glaucoma has become the world's leading cause of irreversible blindness, and one of its
main characteristics is high intraocular pressure. Currently, the non-surgical drug treatment …

The science of diabetes care has progressed to provide a better understanding of the
oxidative and inflammatory lesions and pathophysiology of the neuro-vascular unit within …